TrialClinical genitourinary cancer2013

A randomized phase II trial evaluating different schedules of zoledronic acid on bone mineral density in patients with prostate cancer beginning androgen deprivation therapy.

Joshua M Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.